# Serrantor OCT Study

> **NCT06434194** · NA · RECRUITING · sponsor: **Cagent Vascular LLC** · enrollment: 60 (estimated)

## Conditions studied

- Critical Limb Ischemia

## Interventions

- **DEVICE:** Serranator PTA Serration Catheter
- **DRUG:** PTA (Standard of Care)

## Key facts

- **NCT ID:** NCT06434194
- **Lead sponsor:** Cagent Vascular LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-31
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06434194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06434194, "Serrantor OCT Study". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT06434194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*